Scientists develop targeted therapy for T-cell lymphomas and leukemias

Researchers at the Johns Hopkins Kimmel Cancer Center's Ludwig Center developed a new treatment that selectively targets TRBC2-positive T-cell cancers, expanding a precision approach they established ...
Morning Overview on MSN

This cancer-fighting molecule took 50 years to build

The story of a cancer-fighting molecule that took half a century to build is really a story about how slow, stubborn ...

How AI coding agents work—and what to remember if you use them

At the core of every AI coding agent is a technology called a large language model (LLM), which is a type of neural network ...
Johns Hopkins Medicine

Johns Hopkins Scientists Develop Targeted Therapy for T-Cell Lymphomas and Leukemias

Researchers at the Johns Hopkins Kimmel Cancer Center’s Ludwig Center developed a new treatment that selectively targets ...

When Wall Street Rotates, Biotech Innovators Emerge: The Untapped Opportunities in Oncology

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.